Drug Profile
Follitropin alfa biosimilar - Dong-A ST/Genexine
Alternative Names: DA-3801; Gonadopin; Gonadorphin; GX-F11Latest Information Update: 02 Oct 2021
Price :
$50
*
At a glance
- Originator Dong-A Pharmaceutical
- Developer Dong-A ST
- Class Follicle stimulating hormones; Infertility therapies; Peptide fragments; Pituitary gonadotropins; Recombinant proteins
- Mechanism of Action Ovarian follicle stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
- Available For Licensing Yes - Female infertility
Highest Development Phases
- Marketed Female infertility; Infertility
Most Recent Events
- 18 Mar 2016 Launched for Ovulation induction in anovulatory women in South Korea (Parenteral) (Dong-A ST Annual Report 2015)
- 08 May 2015 Preregistration for Infertility in South Korea (Parenteral)
- 08 May 2015 Dong-A files NDA for Infertility (Anovulation) in South Korea